Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sarilumab vs Etanercept in RA (RA-COMPARE)
NCT01764997Phase 3Terminated
- Sponsor
- Sanofi
- Start
- Apr 2013
- Primary completion
- Jan 2015
- Modality
- Recombinant Proteins and Enzymes, Monoclonal Antibodies
- Countries
- 31
01
Overview
A Phase 3 trial of sarilumab in rheumatoid arthritis (RA), sponsored by Sanofi. Started Apr 2013; status: terminated.
02
Drugs
sarilumab
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT01764997.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01764997.